REGULATORY

• Fanconi Syndrome Found in Majority of Health Damages Tied to Beni-Koji Supplements
  April 10, 2024

• LDP Healthcare Clique Urges Rethink of Rationale for Off-Year Drug Price Revisions
  April 10, 2024

• Lawmakers’ Group on Pollen Allergy to Compile Opinion Paper towards Honebuto
  April 9, 2024

• LDP Generic League to Soon Draw Up Proposal towards Honebuto Policy
  April 9, 2024

• Japan Requests Self-Inspections for All Generic Firms; Report Due by October-End
  April 9, 2024

• MOF Panel Begins Debate for FY2025 Budget Proposal, Mulls Spending Target
  April 5, 2024

• Japan Kicks Off New Reporting System for “Supply Risk” and “Supply Status”
  April 4, 2024

• Offset Technology-Driven Cost Rise with Spending Reforms: Govt Economic Estimate
  April 3, 2024

• Japan Health Minister Hints Positive Stance on Off-Year Price Revisions
  April 3, 2024

• Japan Govt Ends COVID Vaccine Supply as Emergency Program Winds Up
  April 3, 2024

• Opposition Party Head Calls for Rethink of Public Health Coverage in Japan
  April 3, 2024

• Japan Finalizes Generic Info Disclosure Guidelines for Company Indicator Rule
  April 2, 2024

• Japan Revises GMP Inspection Guide after Generic Manufacturing Issues
  April 2, 2024

• Japan’s Amended Next-Gen Medical Infrastructure Law Takes Effect
  April 2, 2024

• Drug Makers in Japan Asked to Create Pediatric Development Plans from April
  April 1, 2024

• MHLW Defines “Long-Listed Products” towards Rollout of New Coverage Rule
  April 1, 2024

• Kobayashi Factory Inspected over Beni-Koji Health Issue
  April 1, 2024

• LDP Lawmakers Call for Penalties against “Dump and Run Away” Generic Makers
  March 29, 2024

• Beni-Koji Issue: MHLW Requests Self-Inspections to Purchasers of Kobayashi’s Red Rice Yeast
  March 29, 2024

• Label Revision Ordered for CAR-T Therapies to Add New Precaution
  March 29, 2024

ページ

• « 先頭
• ‹ Prev
• …
• 51
• 52
• 53
• 54
• 55
• 56
• 57
• 58
• 59
• …
• Next ›
• 最終 »